Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026
EASD 2026 28 September - 2 October 2026

Longitudinal dynamics of cardiometabolic parameters in a MASH population stratified by baseline glycemia and treated with semaglutide: post hoc insights from the ESSENCE trial part 1

Authors :

M. Roden1, M.T. Arias-Loste2, E. Bugianesi3, L. Castera4, N.M. Eklöf5, W. Kim6, N. Krarup5, B. Ludvik7, P.N. Newsome8, V. Ratziu9, A.J. Sanyal10, A. Trifan11, T.C. Vestergaard5, M.E. Rinella12, on behalf of the ESSENCE Study Group
Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download poster (.pdf)
Keywords
MASH
Congress short oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)